When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Type 2 diabetes in children

Última revisión: 15 Jan 2026
Última actualización: 26 Sep 2025

Resumen

Definición

Anamnesis y examen

Principales factores de diagnóstico

  • polyuria
  • polydipsia
  • acanthosis nigricans
  • nocturia
Todos los datos

Otros factores de diagnóstico

  • hypertension
  • yeast infections
  • skin infections
  • urinary tract infections
  • fatigue
  • blurred vision
  • weight loss
Todos los datos

Factores de riesgo

  • obesity
  • genetic predisposition/family history
  • African-American, Hispanic, American-Indian, and Asian or Pacific Islander
  • puberty
  • female sex
  • diabetic in-utero environment
  • small for gestational age
  • rapid growth in infancy
  • bottle feeding
  • high protein intake in infancy
  • polycystic ovaries
  • intramyocellular lipid content
  • fat deposition in the liver
  • learning disability
Todos los datos

Pruebas diagnósticas

Primeras pruebas diagnósticas para solicitar

  • urine dipstick
  • random plasma glucose
  • fasting plasma glucose
  • HbA1c
  • autoantibodies to insulin, islet antigen (IA-2), glutamic acid decarboxylase (GAD), and zinc transporter 8 (ZnT8)
Todos los datos

Pruebas diagnósticas que deben considerarse

  • 2-hour plasma glucose
  • random C-peptide
Todos los datos

Algoritmo de tratamiento

Agudo

ketoacidosis or hyperglycemic hyperosmolar state (HHS)

En curso

HbA1c <8.5%: no acidosis or ketosis

HbA1c ≥8.5%: no acidosis with or without ketosis

Colaboradores

Autores

Jennifer Miller, MD
Jennifer Miller

Professor

Department of Pediatrics

University of Florida

Gainesville

FL

Divulgaciones

JM declares that she has received research funding from Soleno Therapeutics, Harmony Biosciences, and Rhythm Pharmaceuticals. JM is an author of a reference cited in this topic.

Chelsea Zimmerman, MD

Clinical Physician

Pediatric Endocrinology

Endocrinology and Metabolism of East Alabama

Opelika

AL

Divulgaciones

CZ declares that she has no competing interests.

Agradecimientos

Dr Jennifer Miller and Dr Chelsea Zimmerman would like to gratefully acknowledge Dr Arlan Rosenbloom and Dr Paul Hiers, previous contributors to this topic.

Divulgaciones

AR is an author of a number of references cited in this topic. Unfortunately, we have since been made aware that AR is deceased. PH declares that he has no competing interests.

Revisores por pares

Philip Zeitler, MD, PhD

Professor of Pediatrics and Clinical Science

University of Colorado School of Medicine

Aurora

CO

Divulgaciones

PZ declares that he has no competing interests.

Julian P. Hamilton-Shield, MB, ChB, MD(Bristol), MRCP, FRCPCH, FRCPCH

Professor

Diabetes and Metabolic Endocrinology

School of Clinical Sciences

University of Bristol

UK

Divulgaciones

In the past, JPHS received speaking honoraria from Sanofi-Aventis, Roche, Abbott, Novo Nordisk, and Nutricia. None of these talks were directly pertinent to the treatment of type 2 diabetes.

Kristen Nadeau, MD

Professor of Pediatric Endocrinology

University of Colorado School of Medicine

Aurora

CO

Divulgaciones

KN declares that she has no competing interests.

Dennis Styne, MD

Professor of Pediatrics

Rumsey Chair of Pediatric Endocrinology

University of California

Sacramento

CA

Divulgaciones

DS declares that he has no competing interests.

Agradecimiento de los revisores por pares

Los temas de BMJ Best Practice se actualizan de forma continua de acuerdo con los desarrollos en la evidencia y en las guías. Los revisores por pares listados aquí han revisado el contenido al menos una vez durante la historia del tema.

Divulgaciones

Las afiliaciones y divulgaciones de los revisores por pares se refieren al momento de la revisión.

Referencias

Nuestros equipos internos de evidencia y editoriales colaboran con colaboradores expertos internacionales y revisores pares para garantizar que brindemos acceso a la información más clínicamente relevante posible.

Artículos principales

American Diabetes Association. Standards of care in diabetes - 2025. Diabetes care. 2025 Jan;48(suppl 1):S1-352.Texto completo

Shah AS, Barrientos-Pérez M, Chang N, et al. ISPAD clinical practice consensus guidelines 2024: type 2 diabetes in children and adolescents. Horm Res Paediatr. 2024;97(6):555-83.Texto completo  Resumen

Glaser N, Fritsch M, Priyambada L, et al. ISPAD clinical practice consensus guidelines 2022: diabetic ketoacidosis and hyperglycemic hyperosmolar state. Pediatr Diabetes. 2022 Nov;23(7):835-56. Resumen

Artículos de referencia

Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
  • Type 2 diabetes in children images
  • Diferenciales

    • Impaired glucose tolerance
    • Type 1 diabetes mellitus (T1DM)
    • Monogenic diabetes: maturity-onset diabetes of the young
    Más Diferenciales
  • Diretrizes

    • Standards of care in diabetes - 2025
    • Type 2 diabetes in children and adolescents​​
    Más Diretrizes
  • Folhetos informativos para os pacientes

    Diabetes type 2: should I take insulin?

    Diabetes type 2: what are the treatment options?

    Mais Folhetos informativos para os pacientes
  • padlock-lockedConectar-se ou assinar para acessar todo o BMJ Best Practice

O uso deste conteúdo está sujeito ao nosso aviso legal